Can ESR1 rs2234693 alter tissue responsiveness to estradiol?

The ESR1 rs2234693 (PvuII T>C) polymorphism is a functional, non-coding regulatory variant located in intron 1 of the estrogen receptor alpha (ESR1) gene. This variant acts as a key genetic modifier that directly influences how target tissues respond to circulating estradiol levels.

Mechanistic explanations

• Transcription Factor Binding: The C allele of rs2234693 creates a functional binding site for the B-Myb transcription factor that is absent in the T allele. B-Myb acts as an intragenic enhancer, significantly upregulating ESR1 transcription and receptor expression.
• Feed-Forward Loop: Because estradiol upregulates B-Myb, individuals carrying the C allele experience a feed-forward mechanism where estradiol exposure drives higher receptor synthesis and amplified receptor abundance.
• Splicing Alterations: This intronic variant is also implicated in modulating pre-mRNA splicing, modifying transcript processing, and altering the expression and isoform composition of the ER-alpha protein.

Clinical implications

• Tissue Responsiveness: Altered receptor abundance and downstream signaling efficiency directly determine tissue sensitivity to a given estradiol concentration.
• Phenotypic Effects: These genotype-dependent variations in signaling translate to differences in clinical phenotypes, influencing bone mineral density, skeletal muscle injury susceptibility, urogenital responsiveness, and breast cancer progression.

Bottom line

• Strong mechanistic evidence establishes that the ESR1 rs2234693 polymorphism modulates receptor expression and downstream signaling efficiency, ultimately altering individual tissue responsiveness to a given level of estradiol.